Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline to Present Data at the 2021 Virtual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) and the 17th Annual WORLDSymposium™ 2021
Freeline Reports Second Quarter 2022 Financial Results and Business Highlights
Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s Disease
Freeline Appoints Paul Schneider as Chief Financial Officer
Freeline Initiates Dosing of Second Cohort in B-LIEVE Dose Confirmation Trial of FLT180a in Hemophilia B
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels